Company Profile:
Granules India Ltd. is a manufacturer.
Company Introduction:
Granules India Ltd. is a vertically integrated pharmaceutical company headquartered in Hyderabad, India. It is a leading manufacturer of Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages (FDs) for customers across the globe.
The company operates multiple manufacturing facilities that are approved by major regulatory bodies worldwide, including the US FDA, EDQM, and others. Granules India focuses on a multi-product portfolio and a "molecules to medicines" strategy, providing a comprehensive range of products and services within the pharmaceutical supply chain.
With a strong emphasis on research and development, quality, and operational efficiency, Granules India serves various therapeutic areas and has a significant presence in regulated markets such as North America and Europe, as well as emerging markets. Their business model integrates the entire manufacturing process, from raw materials to finished products, making them a key player in the global pharmaceutical industry.
Enterprise Products
Granules India Ltd. manufactures and sells a diverse portfolio of pharmaceutical products, primarily categorized into Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages (FDs).
Active Pharmaceutical Ingredients (APIs) include:
- Paracetamol
- Metformin Hydrochloride
- Ibuprofen
- Guaifenesin
- Naproxen
- Ranitidine Hydrochloride
- Cetirizine Hydrochloride
- Fexofenadine Hydrochloride
- Famotidine
- Omeprazole
- Montelukast Sodium
- Ropinirole Hydrochloride
- Venlafaxine Hydrochloride
- Doxycycline
Pharmaceutical Formulation Intermediates (PFIs) include:
- Paracetamol
- Metformin Hydrochloride
- Ibuprofen
- Guaifenesin
- Naproxen
- Ranitidine Hydrochloride
Finished Dosages (FDs) encompass a wide array of generic products in various dosage forms such as tablets, capsules, and oral suspensions. These products cater to several therapeutic areas, including but not limited to:
- Pain management (e.g., Paracetamol tablets, Ibuprofen tablets)
- Diabetes management (e.g., Metformin tablets)
- Cold and cough relief (e.g., Guaifenesin tablets)
- Antacids (e.g., Famotidine tablets)
- Allergy relief (e.g., Cetirizine tablets)
- Gastric acid reduction (e.g., Omeprazole capsules)
- Asthma and allergy (e.g., Montelukast tablets)
Business Registration Information:
Manager:
Dr. Krishna Prasad Chigurupati
Phone:
E-mail:
investorrelations@granulesindia.com
Official Website:
Address:
2nd Floor, Block C, My Home Hub, Madhapur, Hyderabad, Telangana - 500 081, India
This content is from AI, the data and information provided is for reference only and is not applicable to investment and purchase decisions. If there is any incorrect information, please contact customer service to correct it.